NMDA Antibodies

Santa Cruz Biotechnology features a diverse variety of NMDA Antibodies for investigating N-methyl-D-aspartate receptors in various physiological and pathological processes. NMDA monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). N-methyl-D-aspartate receptors play fundamental roles in synaptic plasticity, learning, and memory, making them central to neurobiology research. Dysregulation of NMDA receptor activity has been linked to numerous neurological disorders, including Alzheimer's disease, schizophrenia, and epilepsy. Understanding NMDA receptor function and modulation opens new possibilities for developing targeted therapeutic approaches. NMDA monoclonal antibodies enable precise detection and characterization of receptor expression patterns across different neural tissues. Investigating NMDA receptor signaling pathways provides valuable insights into synaptic transmission and plasticity mechanisms. NMDA receptor research continues to reveal new aspects of neural communication and development. Santa Cruz Biotechnology monoclonal antibodies for NMDA receptors support researchers worldwide in advancing our understanding of neurological health and disease.